Kidney cancer in the elderly

被引：5

作者：

Kirkali, Ziya ^{[1
]}

机构：

[1] Dokuz Eylul Univ, Sch Med, Dept Urol, Izmir, Turkey

来源：

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | 2009年 / 27卷 / 06期

关键词：

RENAL-CELL CARCINOMA; INDEPENDENT PROGNOSTIC-FACTOR; RADICAL NEPHRECTOMY; INTERFERON-ALPHA; CO-MORBIDITY; YOUNG AGE; TUMORS; SURVIVAL; OLD; ADULTS;

D O I：

10.1016/j.urolonc.2009.07.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Kidney cancer in the elderly patient is a real challenge for the oncologic urologist. With the aging population, we will face more patients with renal cell carcinoma in senior adults. There is evidence that elderly patients with RCC have more aggressive disease and lower cancer-specific survival. Proper assessment of the general status and comorbidity of the patient is essential for treatment planning. Most patients can be operated on by surgery or by minimally invasive techniques and methods. Elderly patients with metastatic kidney cancer can benefit from systemic therapy; however, they should be closely monitored for serious adverse events. (C) 2009 Elsevier Inc. All rights reserved.

引用

页码：673 / 676

页数：4

共 37 条

[1]

[Anonymous], US INTERIM PROJECTIO

[2] Age does not impair the efficacy of immunochemotherapy in patients with metastatic renal carcinoma [J].